Internationally, countries including India, Canada, Brazil, and China have already seen generic launches in 2026 following patent expirations there, but those products are not approved for use in the U.S
In the 1960s, a chelating agent known as "British Anti-Lewisite" (BAL) was modified into DMSA, a related dithiol with far fewer side effects
For patients who were receiving Trulicity for its cardiovascular risk reduction benefits (as demonstrated in the REWIND trial for adults with type 2 diabetes at high cardiovascular risk), discontinuation means this protection may be lost
Christen S et al
If refrigeration is unavailable, patients should calculate whether their medication can remain at room temperature for the entire trip duration based on product-specific guidelines
Tendon injuries, muscle tears, and ligament damage all reportedly respond more rapidly to combination protocols than to either peptide alone